Engagement in HIV care among HIV-positive men who have sex with men from 21 cities in the United States

AIDS and Behavior

Volumn 18, Issue SUPPL. 3, 2014, Pages

  Paz Bailey, Gabriela ^a   Pham, Huong ^b   Oster, Alexandra M ^a   Lansky, Amy ^a   Bingham, Trista ^c   Wiegand, Ryan E ^a   Dinenno, Elizabeth ^a   Skarbinski, Jacek ^a   Heffelfinger, James D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ICF INTERNATIONAL   (United States)

^c Department of Public Health ^*  (United States)

Author keywords

Antiretroviral therapy (ART); HIV AIDS; Linkage to care; Men who have sex with men (MSM); United States

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; HEALTH; HEALTH SURVEY; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN; INTERVIEW; MALE; MALE HOMOSEXUALITY; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT ATTITUDE; PREVALENCE; PROCEDURES; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT ACCEPTANCE OF HEALTH CARE; POPULATION SURVEILLANCE; PREVALENCE; RISK-TAKING; URBAN HEALTH; YOUNG ADULT;

EID: 84898891696     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-013-0605-y     Document Type: Article

References (41)

1. CDC. HIV Surveillance Report, 2010, vol. 22. http://www.cdc.gov/hiv/ surveillance/resources/reports/2010report/pdf/2010-HIV-Surveillance-Report-vol- 22.pdf. Accessed 1 Aug 2013.
2. Prejean J, Song R, Hernandez A, et al. Estimated HIV incidence in the United States, 2006-2009. PLoS One. 2011;6:e17502.
3. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. New Engl J Med. 2011;365:493-505.
4. CDC. Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data - United States and 6 U.S. Dependent Areas, 2010. Atlanta: US Centers for Disease Control and Prevention; 2012.
5. Hall HI, Gray KM, Tang T, Li J, Shouse L, Mermin J. Retention in care of adults and adolescents living with HIV in 13 U.S. areas. J Acquir Immune Defic Syndr. 2012;60:77-82.
6. Giordano TP, Hartman C, Gifford AL, Backus LI, Morgan RO. Predictors of retention in HIV care among a national cohort of US veterans. HIV Clin Trials. 2009;10:299-305.
7. Bamford LP, Ehrenkranz PD, Eberhart MG, Shpaner M, Brady KA. Factors associated with delayed entry into primary HIV medical care after HIV diagnosis. AIDS. 2010;24:928-30.
8. Mugavero MJ, Lin HY, Willig JH, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis. 2009;48:248-56.
9. Hall HI, Frazier EL, Rhodes P, et al. Continuum of HIV care: differences in care and treatment by sex and race/ethnicity in the United States. XIX International AIDS Conference. Washington DC; 2012.
10. Christopoulos KA, Das M, Colfax GN. Linkage and retention in HIV care among men who have sex with men in the United States. Clin Infect Dis. 2011;52(Suppl 2):S214-22.
11. Ulett KB, Willig JH, Lin HY, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDs. 2009;23:41-9.
12. Reed JB, Hanson D, McNaghten AD, et al. HIV testing factors associated with delayed entry into HIV medical care among HIV-infected persons from eighteen states, United States, 2000-2004. AIDS Patient Care STDs. 2009;23:765-73.
13. The White House. National HIV/AIDS Strategy for the United States. Washington, DC: Office of National AIDS Policy; 2010. http://www.whitehouse.gov/ sites/default/files/uploads/NHAS.pdf. Accessed 1 Aug 2013.
14. Gallagher KM, Sullivan PS, Lansky A, Onorato IM. Behavioral surveillance among people at risk for HIV infection in the U.S.: the National HIV Behavioral Surveillance System. Public Health Rep. 2007;122(Suppl 1):32-8.
15. Finlayson TJ, Le B, Smith A, et al. HIV risk, prevention, and testing behaviors among men who have sex with men - National HIV Behavioral Surveillance System, 21 U.S. cities, United States, 2008. MMWR Surveill Summ. 2011;60:1-34.
16. Sanchez T, Finlayson T, Drake A, et al. Human immunodeficiency virus (HIV) risk, prevention, and testing behaviors-United States, National HIV Behavioral Surveillance System: men who have sex with men, November 2003-April 2005. MMWR Surveill Summ. 2006;55:1-16.
17. CDC. Prevalence and awareness of HIV infection among men who have sex with men - 21 cities, United States, 2008. MMWR Morb Mortal Wkly Rep. 2010;59:1201-7.
18. MacKellar DA, Gallagher KM, Finlayson T, Sanchez T, Lansky A, Sullivan PS. Surveillance of HIV risk and prevention behaviors of men who have sex with men: a national application of venue-based, time-space sampling. Public Health Rep. 2007;122(Suppl 1):39-47.
19. Allen DR, Finlayson T, Abdul-Quader A, Lansky A. The role of formative research in the National HIV Behavioral Surveillance System. Public Health Rep. 2009;124:26-33.
20. Mugavero MJ, Davila JA, Nevin CR, Giordano TP. From access to engagement: measuring retention in outpatient HIV clinical care. AIDS Patient Care STDs. 2010;24:607-13.
21. Mancl LA, DeRouen TA. A covariance estimator for GEE with improved small-sample properties. Biometrics. 2001;57:126-34.
22. SAS Institute Inc. SAS/STAT 9.2 User's Guide: SAS Institute Inc., Cary, NC, USA; 2008.
23. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52:793-800.
24. Kalichman SC, Schaper PE, Belcher L, et al. It's like a regular part of gay life: repeat HIV antibody testing among gay and bisexual men. AIDS Educ Prev. 1997;9:41-51.
25. Girardi E, Aloisi MS, Arici C, et al. Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr. 2004;36:951-9.
26. The Affordable Care Act and HIV/AIDS; 2012. http://aids.gov/federal- resources/policies/health-care-reform/. Accessed 13 Mar 2013.
27. Hammer SM, Eron JJ Jr, Reiss P, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008;300:555-70.
28. Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012;308:387-402.
29. NCHS. Data on Health Insurance and Access to Care. 2012. http://www.cdc.gov/nchs/data/factsheets/factsheet-hiac.pdf. Accessed 21 June 2013.
30. Cohen RA, Bloom B. Access to and utilization of medical care for young adults ages 20-29 years: United States, 2008. NCHS Data Brief, No. 29; 2010. http://www.cdc.gov/nchs/data/databriefs/db29.PDF. Accessed 1 Aug 2013.
31. The Henry J. Kaiser Family Foundation. Access to Health Care by Health Insurance Status; 2011. http://kff.org/medicaid/slide/access-to-care-by-health- insurance-status-2011. Accessed 1 Aug 2013.
32. Lillie-Blanton M, Stone VE. Snow Jones A, et al. Association of race, substance abuse, and health insurance coverage with use of highly active antiretroviral therapy among HIV-infected women, 2005. Am J Public Health. 2010;100:1493-9.
33. Kahn JG, Haile B, Kates J, Chang S. Health and federal budgetary effects of increasing access to antiretroviral medications for HIV by expanding Medicaid. Am J Public Health. 2001;91:1464-73.
34. Keruly JC, Conviser R, Moore RD. Association of medical insurance and other factors with receipt of antiretroviral therapy. Am J Public Health. 2002;92:852-7.
35. Cunningham WE, Markson LE, Andersen RM, et al. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States. HCSUS Consortium. HIV Cost and Services Utilization. J Acquir Immune Defic Syndr. 2000;25:115-23.
36. Fleishman JA, Yehia BR, Moore RD, Korthuis PT, Gebo KA, Network HIVR. Establishment, retention, and loss to follow-up in outpatient HIV care. J Acquir Immune Defic Syndr. 2012;60:249-59.
37. Mugavero MJ, Westfall AO, Zinski A, et al. Measuring retention in HIV care: the elusive gold standard. J Acquir Immune Defic Syndr. 2012;61:574-80.
38. Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009;301:2380-2.
39. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48-57.
40. Montaner JS, Hogg R, Wood E, et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet. 2006;368:531-6.
41. Grossman CI, Forsyth A, Purcell DW, Allison S, Toledo C, Gordon CM. Advancing novel HIV prevention intervention research with MSM: meeting report. Public Health Rep. 2011;126:472-9.